Invenia ABUS 2.0
The Invenia ABUS 2.0 by GE Healthcare is a highly effective tool for breast cancer screening and diagnostic imaging, particularly for women with dense breast tissue. Its advanced imaging capabilities, intelligent algorithms, and user-friendly design provide high-resolution 3D images that enhance the detection and characterization of breast abnormalities. As a supplemental tool to mammography, the Invenia ABUS 2.0 improves the overall accuracy of breast cancer screening programs and supports clinicians in providing comprehensive and precise breast care.
Key Features of Invenia ABUS 2.0
1. Automated Imaging:
• Provides consistent and reproducible full-field breast scans, capturing high-resolution 3D images of the entire breast.
2. High-Resolution Imaging:
• Uses advanced ultrasound technology to produce high-resolution images, enhancing the visualization of breast tissue and improving the detection of abnormalities.
3. Intelligent Imaging Algorithms:
• Features intelligent imaging algorithms and software that enhance image quality, optimize breast tissue visualization, and assist in lesion detection.
4. Wide Field of View:
• Offers a wide field of view, allowing for comprehensive coverage of the entire breast, including regions close to the chest wall.
5. User-Friendly Interface:
• Designed with an intuitive and user-friendly interface to streamline workflow and improve ease of use for clinicians.
6. Comfortable Patient Experience:
• Designed to provide a comfortable scanning experience for patients, with a gentle and efficient scanning process.
Clinical Applications of Invenia ABUS 2.0
1. Breast Cancer Screening:• Particularly beneficial for women with dense breast tissue, where traditional mammography may miss small cancers. The high-resolution 3D images can help detect cancers that are not visible on mammograms.
2. Diagnostic Imaging:
• Used for further evaluation of breast abnormalities detected by mammography or physical examination. Provides detailed visualization of lesions, helping to distinguish between benign and malignant masses.
3. Supplemental Screening:
• Acts as a supplemental screening tool in conjunction with mammography, increasing the overall sensitivity and accuracy of breast cancer screening programs.
